Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2008-10-9
pubmed:abstractText
Monoclonal free light chains (FLCs) frequently cause rapidly progressive renal failure in patients with multiple myeloma. Immunoassays which provide quantitative measurement of FLCs in serum, have now been adopted into screening algorithms for multiple myeloma and other lymphoproliferative disorders. The assays indicate monoclonal FLC production by the presence of an abnormal kappa to lambda FLC ratio (reference range 0.26-1.65). Previous work, however, has demonstrated that in patients with renal failure the FLC ratio can be increased above normal with no other evidence of monoclonal proteins suggesting that in this population the range should be extended (reference range 0.37-3.1). This study evaluated the diagnostic sensitivity and specificity of the immunoassays in patients with severe renal failure.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-11274017, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-12194920, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-12401845, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-12583950, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-12780789, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-12823348, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-15054820, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-15774572, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-15902843, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-16040291, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-16682511, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-16858075, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-17165636, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-17229909, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-17408464, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-17488666, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-17768111, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-2183734, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-2601255, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-3621685, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-3937021, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-4165739, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-8547129, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-9060087, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-9536342, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-9641173, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-9713878, http://linkedlifedata.com/resource/pubmed/commentcorrection/18808676-9759684
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1471-2369
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
11
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
pubmed:affiliation
Department of Nephrology, University Hospital Birmingham, UK. cah692@bham.ac.uk
pubmed:publicationType
Journal Article, Comparative Study